Monopar Therapeutics Inc. (MNPR)

Monopar Therapeutics Statistics

Total Valuation

MNPR has a market cap or net worth of $87.22 million. The enterprise value is $68.12 million.

Market Cap	87.22M
Enterprise Value	68.12M

Important Dates

The next estimated earnings date is Friday, November 15, 2024, before market open.

Earnings Date	Nov 15, 2024
Ex-Dividend Date	n/a

Share Statistics

MNPR has 5.14 million shares outstanding. The number of shares has increased by 19.36% in one year.

Shares Outstanding	5.14M
Shares Change (YoY)	+19.36%
Shares Change (QoQ)	+9.60%
Owned by Insiders (%)	8.07%
Owned by Institutions (%)	5.36%
Float	2.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	8.46
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.59

Current Ratio	6.59
Quick Ratio	6.53
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -102.31% and return on invested capital (ROIC) is -67.23%.

Return on Equity (ROE)	-102.31%
Return on Assets (ROA)	-53.44%
Return on Capital (ROIC)	-67.23%
Revenue Per Employee	n/a
Profits Per Employee	-$712,418
Employee Count	10
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +565.10% in the last 52 weeks. The beta is 1.10, so MNPR's price volatility has been higher than the market average.

Beta (5Y)	1.10
52-Week Price Change	+565.10%
50-Day Moving Average	6.46
200-Day Moving Average	4.11
Relative Strength Index (RSI)	60.03
Average Volume (20 Days)	1,432,105

Short Selling Information

The latest short interest is 49,852, so 0.97% of the outstanding shares have been sold short.

Short Interest	49,852
Short Previous Month	112,378
Short % of Shares Out	0.97%
Short % of Float	2.11%
Short Ratio (days to cover)	0.15

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-7.49M
Pretax Income	-7.12M
Net Income	-7.12M
EBITDA	n/a
EBIT	-7.49M
Earnings Per Share (EPS)	-$2.29

Balance Sheet

Cash & Cash Equivalents	7.12M
Total Debt	n/a
Net Cash	7.12M
Net Cash Per Share	$1.38
Equity (Book Value)	6.09M
Book Value Per Share	1.73
Working Capital	6.09M

Cash Flow

Operating Cash Flow	-6.82M
Capital Expenditures	n/a
Free Cash Flow	-6.82M
FCF Per Share	-$1.33

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MNPR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.36%
Shareholder Yield	-19.36%
Earnings Yield	-9.47%
FCF Yield	-9.06%

Analyst Forecast

The average price target for MNPR is $22.00, which is 29.72% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$22.00
Price Target Difference	29.72%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on August 13, 2024. It was a reverse split with a ratio of 0.2:1.

Last Split Date	Aug 13, 2024
Split Type	Reverse
Split Ratio	0.2:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2